Interestingly, in the study conducted by Cheng et al., HHLA2 was co-expressed with both PD-L1 and B7H4 in 13% of cases, and triple-positive specimens were present mainly in stage III lung cancers. This evidence concerns the gene HHLA2 and lung carcinoma.